Caroline Cake is co-founder and CEO of Neu Health, a digital health company redesigning how neurological conditions like Parkinson’s and dementia are monitored, understood, and treated. She was previously CEO of Health Data Research UK, where she led national efforts to scale innovation and deliver data-driven tools across the NHS. At Neu, she draws on both policy expertise and personal insight to close the gap between signal and response.
Dr. Kinan Muhammed is co-founder and Chief Medical Officer at Neu Health. A consultant neurologist and researcher at the University of Oxford, he specializes in Parkinson’s and Alzheimer’s disease, with a focus on the cognitive and motivational changes that shape patient experience. He has authored research on digital biomarkers and early detection strategies in neurodegenerative disease, and previously held fellowships from the Wellcome Trust and the NIHR. At Neu, he leads clinical direction and research.
Much of today’s care infrastructure was built for a different era, when medicine focused on acute illnesses and short-term fixes. But neurodegenerative diseases don’t follow that script, and neither can we. We have the tools to build something better: care that stays with people, adapts to their needs, and helps them live not just longer, but better.